Archives of Physical Medicine and Rehabilitation
Volume 87, Issue 10 , Pages 1346-1351 , October 2006

Botulinum Toxin Type A for Poststroke Cricopharyngeal Muscle Dysfunction

  • Deog Young Kim, MD, PhD

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
  • ,
  • Chang-il Park, MD, PhD

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
  • ,
  • Suk Hoon Ohn, MD

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
    • Corresponding Author InformationReprint requests to Suk Hoon Ohn, MD, Rehabilitation Hospital, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul, 120-752, South Korea
  • ,
  • Ja Young Moon, MD

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
  • ,
  • Won Hyuk Chang, MD, MS

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
  • ,
  • Seung-woo Park, MD, PhD

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

  • Image Result

    Change in clinical symptom score after BTX-A injection. Abbreviation: T, time. *Significant at P<.05.

    Change in clinical symptom score after BTX-A injection. Abbreviation: T, time. *Significant at P<.05.

  • Image Result

    Change in disability rating scale score for swallowing impairment after BTX-A injection. *Significant at P<.05.

    Change in disability rating scale score for swallowing impairment after BTX-A injection. *Significant at P<.05.

  • Image Result

    Change in body weight after BTX-A injection. *Significant at P<.05.

    Change in body weight after BTX-A injection. *Significant at P<.05.

  • Image Result

    Change of residue in piriform sinus after BTX-A injection. *Significant at P<.05.

    Change of residue in piriform sinus after BTX-A injection. *Significant at P<.05.

  • Image Result

    Change of pharyngeal transit time (PTT) after BTX-A injection.

    Change of pharyngeal transit time (PTT) after BTX-A injection.

  • Image Result

    Change of UES pressure after BTX-A injection. *Significant at P<.05.

    Change of UES pressure after BTX-A injection. *Significant at P<.05.

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(06)00724-6

doi: 10.1016/j.apmr.2006.06.018

Archives of Physical Medicine and Rehabilitation
Volume 87, Issue 10 , Pages 1346-1351 , October 2006